The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMC 1453163)

Published in Immunology on October 01, 1986

Authors

M G Bruce, A Ferguson

Articles citing this

Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58

The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A (1996) 1.42

Oral tolerance. Proc Natl Acad Sci U S A (1994) 1.35

The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19

Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest (2000) 1.14

Oral tolerance. J Clin Immunol (1998) 1.11

Antigen processing by isolated rat intestinal villus enterocytes. Immunology (1989) 1.08

Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release (2011) 1.05

Oral tolerance in protein-deprived mice. II. Evidence of normal 'gut processing' of ovalbumin, but suppressor cell deficiency, in deprived mice. Immunology (1987) 0.96

Irradiated mice lose the capacity to 'process' fed antigen for systemic tolerance of delayed-type hypersensitivity. Clin Exp Immunol (1987) 0.90

Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system. Immunology (1994) 0.87

Tolerance and bystander suppression, with involvement of CD25-positive cells, is induced in rats receiving serum from ovalbumin-fed donors. Immunology (2000) 0.86

Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction. Immunology (2006) 0.82

Antigen uptake and trafficking in human intestinal epithelial cells. Dig Dis Sci (2000) 0.82

Partial characterization of a circulating tolerogenic moiety which, after a feed of ovalbumin, suppresses delayed-type hypersensitivity in recipient mice. Immunology (1995) 0.78

In mice, gluten in maternal diet primes systemic immune responses to gliadin in offspring. Immunology (1988) 0.78

Transfer of cow's milk beta-lactoglobulin to human serum after a milk load: a pilot study. Gut (1993) 0.78

Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case. Microb Cell Fact (2014) 0.77

Divalent hapten-induced intestinal anaphylaxis in the mouse: uptake and characterization of a bystander protein. Immunology (1989) 0.75

Articles by these authors

Quantitation of intraepithelial lymphocytes in human jejunum. Gut (1971) 6.18

Frequency of "functional" gastrointestinal disorders. Lancet (1977) 5.73

Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease. Lancet (1990) 3.37

Intraepithelial lymphocytes of the small intestine. Gut (1977) 3.21

The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse. Clin Exp Immunol (1972) 3.09

Selective migration of lymphocytes within the mouse small intestine. Immunology (1974) 3.06

A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98

Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91

Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68

Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50

Intestinal inflammation in cystic fibrosis. Arch Dis Child (2000) 2.46

Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology (1994) 2.45

Too many patients, too few cardiologists to care? Can J Cardiol (2006) 2.45

The effects of different component response requirements in multiple and concurrent schedules. J Exp Anal Behav (1978) 2.43

Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41

Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34

Intraepithelial cells in the human intestinal mucosa. J Ultrastruct Res (1971) 2.31

Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children. Br Med J (1972) 2.25

Mortality in celiac disease. Gastroenterology (1989) 2.24

Failure to record variables of growth and development in children with inflammatory bowel disease. BMJ (1989) 2.22

Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11

Lymphocytes in Whipple's disease. Lancet (1968) 2.06

Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics. Cell Tissue Kinet (1977) 2.00

Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99

Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation. Fertil Steril (1989) 1.98

Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology (1982) 1.92

Hypersensitivity in the small intestinal mucosa. V. Induction of cell-mediated immunity to a dietary antigen. Clin Exp Immunol (1981) 1.91

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89

A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85

Gastrointestinal amyloidosis in psoriatic arthritis. Ann Rheum Dis (1968) 1.81

Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77

Hypersensitivity reactions in small intestine. I Thymus dependence of experimental 'partial villous atrophy'. Gut (1975) 1.74

Intraepithelial lymphocyte counts in small intestinal biopsies from children with diarrhoea. Acta Paediatr Scand (1976) 1.73

Molecular mechanisms of immunoglobulin A defense. Annu Rev Microbiol (1989) 1.70

Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70

Growth and development of "antigen-free" grafts of foetal mouse intestine. J Pathol (1972) 1.68

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67

Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut (1989) 1.64

Adult coeliac disease in hyposplenic patients. Lancet (1970) 1.63

Hypersensitivity reactions in the small intestine. 2. Effects of allograft rejection on mucosal architecture and lymphoid cell infiltrate. Gut (1976) 1.62

Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology (1993) 1.61

Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut (1991) 1.61

Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res (1984) 1.60

Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet (1995) 1.59

Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med (1990) 1.56

Hypersensitivity reactions in the small intestine. 6. Pathogenesis of the graft-versus-host reaction in the small intestinal mucosa of the mouse. Transplantation (1981) 1.54

Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex Transm Infect (2006) 1.53

Use of whole-gut lavage to measure intestinal immunity in healthy Sierra Leonean children. J Pediatr Gastroenterol Nutr (1994) 1.51

Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut (1984) 1.49

An analysis of cases incorrectly coded as inflammatory bowel disease in Scottish Hospital In-Patient Statistics (SHIPS). Scott Med J (1991) 1.49

Mucosa-associated bacterial flora of the human colon. J Med Microbiol (1997) 1.47

Oral tolerance to ovalbumin in mice: studies of chemically modified and 'biologically filtered' antigen. Immunology (1986) 1.46

Breast-feeding of very low birth weight infants. J Pediatr (1993) 1.45

Technique for microdissection and measurement in biopsies of human small intestine. J Clin Pathol (1977) 1.44

Ulcerative colitis and Crohn's disease. BMJ (1994) 1.43

Histopathology and time course of rejection of allografts of mouse small intestine. Transplantation (1973) 1.42

Effects of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis. Scand J Gastroenterol (1987) 1.39

Genetic aetiology of lactose intolerance. Lancet (1967) 1.39

Appraisal of gut lavage in the study of intestinal humoral immunity. Gut (1990) 1.39

Detection of mutations associated with colorectal cancer in DNA from whole-gut lavage fluid. J Natl Cancer Inst (1998) 1.38

Duodenal mucosal architecture in non-specific and ulcer-associated duodenitis. Gut (1981) 1.31

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut (1997) 1.30

Quality of health care and its effects in the utilisation of maternal and child health services in Kenya. East Afr Med J (2005) 1.28

Incidence of juvenile-onset Crohn's disease in Scotland. Lancet (1999) 1.25

Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr (1991) 1.23

Effect of T cell depletion on the potentiated reagin response. Nature (1974) 1.22

Oral tolerance in protein-deprived mice. I. Profound antibody tolerance but impaired DTH tolerance after antigen feeding. Immunology (1987) 1.21

Effects of local delayed hypersensitivity on the small intestine. Ciba Found Symp (1978) 1.20

Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet (1999) 1.20

Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res (1995) 1.20

Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J Med Genet (1999) 1.16

Autoantibodies in children with coeliac disease. Clin Exp Immunol (1973) 1.15

Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet (1997) 1.15

Coeliac disease in Edinburgh and the Lothians 1900-1980. Scott Med J (1982) 1.15

Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut (2001) 1.15

Serological diagnosis of idiopathic Addison's disease in patients on prolonged prednisolone therapy for steatorrhoea. Lancet (1969) 1.14

Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med (1996) 1.14

Fluid replacement after appendicectomy or cholecystectomy. A comparison of oral glucose-electrolyte solution with intravenous fluids. J R Coll Surg Edinb (1987) 1.13

Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed (2005) 1.13

Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours. Gut (1990) 1.12

Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet (1992) 1.12

Neglect of growth and development in the clinical monitoring of children and teenagers with inflammatory bowel disease: review of case records. BMJ (1998) 1.11

Ulcerative colitis. BMJ (2000) 1.11

The incidence of thyroglobulin antibodies and thyroid enlargement in a general practice in north-east England. Clin Exp Immunol (1966) 1.11

Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment Pharmacol Ther (2006) 1.11

Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease. Gastroenterology (1993) 1.11

Why study T cell subsets in Crohn's disease? Gut (1983) 1.10

Small intestinal epithelial cell kinetics and protozoal infection in mice. Gastroenterology (1978) 1.10

Features of small intestinal pathology (epithelial cell kinetics, intraepithelial lymphocytes, disaccharidases) in a primary Giardia muris infection. Gut (1982) 1.09

Animal model of gluten induced enteropathy in mice. Gut (1991) 1.08

Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut (1983) 1.08

Cord blood IgE: its determinants and prediction of development of asthma and other allergic disorders at 12 months. Ann Allergy Asthma Immunol (2000) 1.08

The clinical entity of orofacial Crohn's disease. Q J Med (1991) 1.07

Food antibodies in oral disease: a study of serum antibodies to food proteins in aphthous ulceration and other oral diseases. J Clin Pathol (1973) 1.04

Dermatitis herpetiformis in two patients with idiopathic steatorrhoea (adult coeliac disease). Br Med J (1968) 1.04

Hazards of hyposplenism. Br Med J (Clin Res Ed) (1982) 1.04

Pre- and postweaning disaccharidase patterns in isografts of fetal mouse intestine. Gastroenterology (1973) 1.04

Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance. J Immunol (1990) 1.03

Histochemical demonstration of chymotrypsin like serine esterases in mucosal mast cells in four species including man. J Clin Pathol (1985) 1.03